Skip to content

Contact +44 (0) 20 7060 7474 email us

General Industry

World Pharmaceutical Market (2007)

 

Publication Date November 2006
Publisher RNCOS
Product Type
Pages 75
ISBN Number not applicable
Product Code RCS00294

Price

£490.00
approximately: $742 | €547

pdf

Buy Now

print £845 ($1,279 | €943)

Buy Now

cdrom £560 ($848 | €625)

Buy Now

Order above formats by FAX

Order by Fax

Summary

RNCOS' report, "World Pharmaceutical Market (2007)", provides an extensive overview of Pharmaceutical industry on a worldwide level. The report provides the authentic data on past and current performance of the Pharmaceutical industry. Not only this, it also looks closely at the various issues relevant to the Pharmaceutical industry.

Key Findings

  • The global Pharmaceuticals Market has demonstrated consistent strong growth patterns in the last five years generating total revenues of US$ 534.8 Billion in 2005.
  • Much of the growth in the Global Pharmaceutical industry can be attributed to the change in the disease profile of the global population. Increasing incidence of lifestyle related diseases have led to an increase in demand for drugs for these particular categories.
  • North America remains the largest Pharmaceutical market constituting 49% of the worldwide market followed by Europe and Asia-Pacific.
  • Pharmaceutical market across the world is witnessing increased opportunities in the area of Bio Pharmaceuticals, Pharmacogenomics and Biologics market.
  • The smaller national markets in Asia-Pacific and Latin America are expected to grow significantly and will increase their presence in the global Pharmaceutical landscape.

Key Issues and Facts Analyzed

The research report also addresses the issues and facts that are critical to the success of Pharmaceutical industry on a Global level.

  • What are the emerging trends in the Global Pharmaceutical sector?
  • What are the future prospects of the Pharmaceutical industry in various regions across the world?
  • Who are the Key players in the Pharmaceutical market?
  • What opportunities exist in the Pharmaceutical market?
  • What Challenges are being faced by the industry?

Key Players Analyzed

This section provides an overview of the key financial facts and information about the prominent players in the Worldwide Pharmaceutical market like Pfizer, Johnson and Johnson, Wayeth, Merck & Co, GlaxoSmithkline and Novartis.

Research Methodology Used

Information Sources

Information has been sourced from various sources namely books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, industry news and developments and through access to more than 3000 paid databases.

Analysis methods
The analysis methods includes the following: Ratio Analysis, Historical Trend Analysis, Linear Regression Analysis using software tools, Judgmental Forecasting and Cause and Effect Analysis.

Contents

  • 1. Analyst View
  • 2. Research Overview
  • 3. Industry Overview
    • 3.1 Worldwide Therapeutic Segmentation in the Pharmaceutical Market
    • 3.2 Worldwide Pharmaceutical Market Segmentation by Region
    • 3.3 Worldwide Expenditure on Pharmaceutical Drugs
    • 3.4 Worldwide Emerging Markets in Pharmaceutical Industry
  • 4. Industry Performance
    • 4.1 By Vendors
    • 4.2 By Therapy Classes and Products
      • 4.2.1 Therapy Classes
      • 4.2.2 Product Classes
        • 4.2.2.1 Biologics Market
        • 4.2.2.2 Block Buster Products
        • 4.2.2.3 Over the Counter Products (OTC)
    • 4.3 By Geographical Spread
      • 4.3.1 Asia-Pacific
        • 4.3.1.1 India
        • 4.3.1.2 China
        • 4.3.1.3 Australia
        • 4.3.1.4 Japan
        • 4.3.1.5 Indonesia
        • 4.3.1.6 Hong Kong
        • 4.3.1.7 South Korea
      • 4.3.2 Europe
        • 4.3.2.1 United Kingdom
        • 4.3.2.2 France
        • 4.3.2.3 Germany
      • 4.3.3 Latin America
        • 4.3.3.1 Mexico
        • 4.3.3.2 Brazil
        • 4.3.3.3 Chile
      • 4.3.4 North America
        • 4.3.4.1 United States of America
        • 4.3.4.2 Canada
      • 4.3.5 Africa
        • 4.3.5.1 South Africa
        • 4.3.5.2 Egypt
        • 4.3.5.3 Saudi Arabia
    • 5. Key Driving Forces
    • 6. Opportunities and Challenges
    • 7. Future Outlook, 2010
    • 8. Key Players
      • 8.1 GlaxoSmithKline
      • 8.2 AstraZeneca
      • 8.3 Johnson & Johnson
      • 8.4 Roche
      • 8.5 Merck & Co.
      • 8.6 Novartis
      • 8.7 Wyeth
      • 8.8 Bristol-Myers Squibb
      • 8.9 Ranbaxy Laboratories Ltd.
    • List of Figures:
      • Figure 3-1: Worldwide - Pharmaceutical Market Revenue (in Billion US$), 2001-2005
      • Figure 3-2: Worldwide - Pharmaceutical Market by Therapeutic Segmentation (%), 2004
      • Figure 3-3: Worldwide - Pharmaceutical Market Segment by Region (%), 2004
      • Figure 3-4: Worldwide - Annual Pharmaceutical Expenditure/Head by Country (in US$), 2003
      • Figure 4-1: Worldwide - Growth in Biologics Market (in Billion US$), 2004 & 2005
      • Figure 4-2: Worldwide - Over the Counter Products Sales (in Billion US$), 2001-2005
      • Figure 4-3: India - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-4: China - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-5: China - Population Aged above 65 Years (%), 2006-2011
      • Figure 4-6: China - GDP Growth (in Trillion US$), 2001-2011E
      • Figure 4-7: Australia - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-8: Australia - Pharmaceutical Expenditure by Government (in Billion Aus$), 2001-2003
      • Figure 4-9: Japan - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-10: Indonesia - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-11: Hong Kong - Pharmaceutical Sales Market (in Million US$), 2000-2005
      • Figure 4-12: South Korea - Pharmaceutical Market Revenue (in Billion US$), 2001-2005
      • Figure 4-13: United Kingdom - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-14: France - Generic Drugs Sale (in Million US$), 2000-2004
      • Figure 4-15: France - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-16: Germany - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-17: Germany - Increase in Life Expectancy (in Year), 2006-2010
      • Figure 4-18: Germany - Forecast of Pharmaceutical Sales (in Billion US$), 2006-2010
      • Figure 4-19: Mexico - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-20: Brazil - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-21: Chile - Pharmaceutical Sales Market (in Million US$), 2001-2005
      • Figure 4-22: USA - Pharmaceutical Sales Market (in Billion US$), 2001-2005
      • Figure 4-23: USA - Forecast of Clinical Trial Business (in Billion US$), 2006-2011
      • Figure 4-24: Canada - Pharmaceutical Sales Market (in Billion US$), 2000-2005
      • Figure 4-25: South Africa - Pharmaceutical Market Revenue (in Billion US$), 2001-2005
      • Figure 5-1: Worldwide - Average Life Expectancy (in Year), 2001-2005
      • Figure 5-2: Worldwide - Annual Spending in Healthcare (in US$/Head), 2001-2005
      • Figure 5-3: Worldwide - Number of Block Buster Drugs (2000 & 2005)
      • Figure 5-4: Worldwide - Growth in Over the Counter Drugs Sale (in Billion US$), 2004 & 2005
      • Figure 6-1: Worldwide - Forecast of Clinical Trial Market (in Billion US$), 2006 & 2007
      • Figure 6-2: Worldwide - Forecast for Enzyme Inhibitor Market (in Billion US$), 2006-2011
      • Figure 6-3: Worldwide - Forecast for Plant Derived Drugs & Applications Market (in Billion US$), 2006-2011
      • Figure 6-4: Worldwide - Growth in Plant Derived Drugs Sale (in Billion US$), 2005, 2006 & 2011
      • Figure 6-5: Worldwide - Growth of Influenza Therapeutics Market (in Billion US$), 2006-2010
      • Figure 6-6: Worldwide - Growth of Pharmacogenomics Market (in Billion US$), 2006-2009
      • Figure 6-7: Worldwide - Growth of Contract Manufacturing (in Billion US$), 2006-2009
      • Figure 6-8: Worldwide - Anti-infective Market (in Billion US$), 2006-2010
      • Figure 7-1: Worldwide - Forecast of Pharmaceutical Market (in Billion US$), 2006-2010
      • Figure 7-2: Worldwide - Application Market for RFID Technology in Pharmaceutical Industry (in Billion US$), 2006-2011
      • Figure 8-1: GlaxoSmithKline - Stock Performance
      • Figure 8-2: AstraZeneca - Stock Performance
      • Figure 8-3: Johnson & Johnson - Stock Performance
      • Figure 8-4: Roche - Stock Performance
      • Figure 8-5: Merck & Co. - Stock Performance
      • Figure 8-6: Norvatis - Stock Performance
      • Figure 8-7: Wyeth - Stock Performance
      • Figure 8-8: Bristol-Myers Squibb - Stock Performance
      • Figure 8-9: Ranbaxy Laboratories Ltd. - Stock Performance
    • List of Tables:
      • Table 4-1: Worldwide - Pharmaceutical Sales by Top 10 Vendors (in Billion US$), 2005
      • Table 4-2: Worldwide - Pharmaceutical Sales by Major Therapy Classes (in Billion US$), 2005
      • Table 4-3: Worldwide - Pharmaceutical Sales by Leading Product Category (in Billion US$), 2005
      • Table 4-4: Worldwide - Over the Counter Drugs Sale by Therapy Classes (in Billion US$), 2005
      • Table 4-5: Worldwide - Over the Counter Drugs Market by Company (in Billion US$), 2005
      • Table 8-1: GlaxoSmithKline - Key Financial Overview (in Million US$), 2001-2005
      • Table 8-2: AstraZeneca - Key Financial Overview (in Million US$), 2005 & 2006
      • Table 8-3: Johnson & Johnson - Key Financial Overview (in Million US$), 2003-2005
      • Table 8-4: Roche - Key Financial Overview (in Million US$), 2005
      • Table 8-5: Merck & Co. - Key Financial Overview (in Million US$), 2003-2005
      • Table 8-6: Novartis - Key Financial Overview (in Million US$), 2001-2005
      • Table 8-7: Wyeth - Key Financial Overview (in Million US$), 2001-2005
      • Table 8-8: Bristol-Myers Squibb - Key Financial Overview (in Million US$), 2001-2005
      • Table 8-9: Ranbaxy Laboratories Ltd. - Key Financial Overview (in Million US$), 2002-2004